Compare Nuvama Wealth with Similar Stocks
Stock DNA
Capital Markets
INR 31,539 Cr (Small Cap)
29.00
20
1.64%
2.80
25.26%
7.53
Total Returns (Price + Dividend) 
Latest dividend: 14.000000000000002 per share ex-dividend date: May-15-2026
Risk Adjusted Returns v/s 
Returns Beta
News

Nuvama Wealth Management Ltd is Rated Sell
Nuvama Wealth Management Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 September 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Nuvama Wealth Management Ltd Faces Technical Setback Amid Price Momentum Shift
Nuvama Wealth Management Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from a mildly bullish stance to a sideways trend. Despite a strong year-to-date return of 12.8%, the stock’s recent price action and technical parameters suggest caution for investors navigating the capital markets sector.
Read full news article
Nuvama Wealth Management Ltd Sees Technical Momentum Shift Amid Strong Price Gains
Nuvama Wealth Management Ltd has exhibited a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish stance as of early September 2026. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, and moving averages, reflecting a nuanced market sentiment despite the stock’s robust price appreciation relative to the broader Sensex index.
Read full news article Announcements 
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
12-Sep-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Catalyst Trusteeship Ltd
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
11-Sep-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for DB Trustees (Hong Kong) Ltd
Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.
11-Sep-2026 | Source : BSEThe Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on September 11 2026 for PAGAC Ecstasy Pte Ltd
Corporate Actions 
No Upcoming Board Meetings
Nuvama Wealth Management Ltd has declared 700% dividend, ex-date: 15 May 26
Nuvama Wealth Management Ltd has announced 2:10 stock split, ex-date: 26 Dec 25
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
62.8049
Held by 23 Schemes (6.77%)
Held by 197 FIIs (19.0%)
Pagac Ecstasy Pte Ltd (53.12%)
Smallcap World Fund, Inc (4.93%)
14.22%
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
QoQ Growth in quarter ended Jun 2026 is 8.44% vs 14.94% in Mar 2026
QoQ Growth in quarter ended Jun 2026 is 13.61% vs 6.05% in Mar 2026
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 12.64% vs 44.91% in Sep 2024
Growth in half year ended Sep 2025 is 8.24% vs 78.44% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 10.63% vs 36.64% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 5.63% vs 64.37% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 11.36% vs 31.76% in Mar 2025
YoY Growth in year ended Mar 2026 is 5.56% vs 57.71% in Mar 2025






